259 related articles for article (PubMed ID: 22231417)
1. Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.
Michaels BM; Csank GA; Ryb GE; Eko FN; Rubin A
Aesthet Surg J; 2012 Jan; 32(1):96-102. PubMed ID: 22231417
[TBL] [Abstract][Full Text] [Related]
2. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
[TBL] [Abstract][Full Text] [Related]
3. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.
Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS
Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460
[TBL] [Abstract][Full Text] [Related]
4. Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study.
Choi JW; Youn CS; An HT; Yoo JY; Na JI; Park KC; Youn SW; Huh CH
J Dermatolog Treat; 2013 Apr; 24(2):126-32. PubMed ID: 21801115
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
Brandt F; Swanson N; Baumann L; Huber B
Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox(®) ) or abobotulinumtoxinA (Dysport(®) ) make a difference?
Ravindra P; Jackson BL; Parkinson RJ
BJU Int; 2013 Jul; 112(1):94-9. PubMed ID: 23490404
[TBL] [Abstract][Full Text] [Related]
7. Overview of Botulinum Toxins for Aesthetic Uses.
Gart MS; Gutowski KA
Clin Plast Surg; 2016 Jul; 43(3):459-71. PubMed ID: 27363760
[TBL] [Abstract][Full Text] [Related]
8. A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles.
Yeilding RH; Fezza JP
Plast Reconstr Surg; 2015 May; 135(5):1328-1335. PubMed ID: 25919246
[TBL] [Abstract][Full Text] [Related]
9. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
Pribitkin EA; Greco TM; Goode RL; Keane WM
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):321-6. PubMed ID: 9076240
[TBL] [Abstract][Full Text] [Related]
10. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
Baumann L; Brandt FS; Kane MA; Donofrio LM
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S57-65. PubMed ID: 19945006
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses From Randomized, Double-Blind Pivotal Studies.
Jones DH; Kerscher M; Geister T; Hast MA; Weissenberger P
Dermatol Surg; 2017 Nov; 43 Suppl 2():S235-S241. PubMed ID: 29064991
[TBL] [Abstract][Full Text] [Related]
12. Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.
Hexsel D; Hexsel C; Siega C; Schilling-Souza J; Rotta FT; Rodrigues TC
JAMA Dermatol; 2013 Dec; 149(12):1386-91. PubMed ID: 24108521
[TBL] [Abstract][Full Text] [Related]
13. Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.
Nestor M; Ablon G; Pickett A
Aesthet Surg J; 2017 May; 37(suppl_1):S20-S31. PubMed ID: 28388717
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
Kaufman-Janette J; Cox SE; Dayan S; Joseph J
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357966
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
16. Comparing the clinical attributes of abobotulinumtoxinA and onabotulinumtoxinA utilizing a novel contralateral Frontalis model and the Frontalis Activity Measurement Standard.
Nestor MS; Ablon GR
J Drugs Dermatol; 2011 Oct; 10(10):1148-57. PubMed ID: 21968665
[TBL] [Abstract][Full Text] [Related]
17. A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.
Grimes PE; Shabazz D
Dermatol Surg; 2009 Mar; 35(3):429-35; discussion 435-6. PubMed ID: 19250310
[TBL] [Abstract][Full Text] [Related]
18. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I
Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918
[TBL] [Abstract][Full Text] [Related]
19. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
Vergilis-Kalner IJ
J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
[TBL] [Abstract][Full Text] [Related]
20. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]